experience of treatment with fenspiride in children with chronic exudative otitis media after tympanostomy

experience of treatment with fenspiride in children with chronic exudative otitis media after tympanostomy

;L.A. Toropova;T.V. Zhuikova;N.I. Marysheva;A.I. Nikolaeva;Yu.S. Maiorova
Biocontrol science 2009 Vol. 8 pp. 102-105
117
toropova2009voprosyexperience

Abstract

The trial presents the analysis of factors predisposing to exudative otitis media development in 709 children, needing regular audiologist’s check-up. It was shown that dominating risk factor of auditory tube’s function disorders is hypertrophy of palatine tonsil (it was detected in 69% of children). Besides, doctors from children’s out-patient clinics often use conservative treatment in children with chronic exudative otitis media. Analysis of data obtained at the time of treatment of 180 hospitalized children under the age 1–17 years old with exudative otitis media showed that combination of tympanostomy with fenspiride (Erespal) allows achieving of more significant decrease (1.3 times low) audibility threshold of different oscillations than in children from control (treated without fenspiride).
Key words: children, exudative otitis media, timpanostomy, fenspiride.
(Voprosy sovremennoi pediatrii — Current Pediatrics. 2009;8(4):102-105)

Keywords

Citation

ID: 231133
Ref Key: toropova2009voprosyexperience
Use this key to autocite in SciMatic or Thesis Manager

References

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
231133
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet

Saymatik Web3.0 Wallet